GB884629A - Pharmaceutical compositions comprising 5:5-hexamethylenehydantoin - Google Patents

Pharmaceutical compositions comprising 5:5-hexamethylenehydantoin

Info

Publication number
GB884629A
GB884629A GB17482/59A GB1748259A GB884629A GB 884629 A GB884629 A GB 884629A GB 17482/59 A GB17482/59 A GB 17482/59A GB 1748259 A GB1748259 A GB 1748259A GB 884629 A GB884629 A GB 884629A
Authority
GB
United Kingdom
Prior art keywords
aqueous
hexamethylenehydantoin
compositions
pharmaceutical compositions
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB17482/59A
Other languages
English (en)
Inventor
Harold Crowther Brimelow
Charles Henry Vasey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB17482/59A priority Critical patent/GB884629A/en
Priority to FR837331A priority patent/FR542M/fr
Publication of GB884629A publication Critical patent/GB884629A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB17482/59A 1959-05-22 1959-05-22 Pharmaceutical compositions comprising 5:5-hexamethylenehydantoin Expired GB884629A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB17482/59A GB884629A (en) 1959-05-22 1959-05-22 Pharmaceutical compositions comprising 5:5-hexamethylenehydantoin
FR837331A FR542M (cs) 1959-05-22 1960-08-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB17482/59A GB884629A (en) 1959-05-22 1959-05-22 Pharmaceutical compositions comprising 5:5-hexamethylenehydantoin

Publications (1)

Publication Number Publication Date
GB884629A true GB884629A (en) 1961-12-13

Family

ID=10095940

Family Applications (1)

Application Number Title Priority Date Filing Date
GB17482/59A Expired GB884629A (en) 1959-05-22 1959-05-22 Pharmaceutical compositions comprising 5:5-hexamethylenehydantoin

Country Status (2)

Country Link
FR (1) FR542M (cs)
GB (1) GB884629A (cs)

Also Published As

Publication number Publication date
FR542M (cs) 1961-05-29

Similar Documents

Publication Publication Date Title
GB1054104A (cs)
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
GB884629A (en) Pharmaceutical compositions comprising 5:5-hexamethylenehydantoin
GB1049996A (en) New medicine with anti-inflammatory and anti-rheumatic activity
GB1126353A (en) Isoquinolinobenzodiazepine derivatives
JPS5793913A (en) Enhancing agent for spermous vital power
GB1099655A (en) An anode plate for an x-ray tube
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
GB1422745A (en) Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same
GB1058516A (en) Contrast agent for medical use
GB563011A (en) Sealed capsules
GB911179A (en) Hypnotic and tranquilizing compositions comprising 4, 6-dimethyl-3-pyridazone
GB1023371A (en) Medicinal compositions containing dipotassium mucate
GB918066A (en) 1,2-diphenyl-4-carbamoyl-3,5-pyrazolidinedione and salts
GB1379959A (en) Pyrrolidino hydroxy-pentanes
GB958575A (en) Vaccines containing clostridium perfringens ª‰-toxoid
GB1300486A (en) Compositions for the treatment of respiratory ailments in man
USD206493S (en) Blister package
GB1001314A (en) Pharmaceutical preparations for combating parasitic helminths
GB870888A (en) Substituted piperazinone
ES199487A1 (es) Un procedimiento de recuperar vitaminas b12 y sustancias similares a la vitamina b12 desde un absorbente de montmorillonita
GB1120964A (en) Pharmaceutical compositions containing glycol polymers
Bernheim NOCTURNAL GASTRIC SECRETION IN DUODENAL ULCER
JPS5780318A (en) Hard capsule containing liquid
GB908634A (en) Pharmaceutical compositions containing pararosaniline or derivatives thereof